vigabatrin has been researched along with Migraine Disorders in 2 studies
Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leniger, T | 1 |
| Wiemann, M | 1 |
| Bingmann, D | 1 |
| Hufnagel, A | 1 |
| Bonnet, U | 1 |
2 other studies available for vigabatrin and Migraine Disorders
| Article | Year |
|---|---|
Vigabatrin. GVG, MDL 71754, RMI 71754, Sabril, Sabrilex, gamma-vinyl-GABA.
Topics: Adult; Clinical Trials as Topic; Dopamine Antagonists; Double-Blind Method; Drug Interactions; Half- | 1999 |
Different effects of GABAergic anticonvulsants on 4-aminopyridine-induced spontaneous GABAergic hyperpolarizations of hippocampal pyramidal cells--implication for their potency in migraine therapy.
Topics: 4-Aminopyridine; Acetates; Amines; Analgesics; Animals; Anticonvulsants; Convulsants; Cyclohexanecar | 2000 |